Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Texas · 89th Legislature (2025) · Bill

HB 3785: Relating to labeling requirements for compounded drug products.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 3785 is a bill introduced in the Texas House on March 5, 2025. According to its official title, it concerns: Relating to labeling requirements for compounded drug products. Primary sponsor: Barbara Gervin-Hawkins (Democratic). Most recent recorded action (April 28, 2025): Failed to receive affirmative vote in comm.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Barbara Gervin-HawkinsPrimary sponsorDemocraticHouse120

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Failed to receive affirmative vote in comm.
  2. Committee substitute considered in committee
  3. Considered in public hearing
  4. Left pending in committee
  5. Testimony taken/registration(s) recorded in committee
  6. Considered in public hearing
  7. Referred to Public Health
  8. Read first time
  9. Filed

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source